Send feedback

SMARCD2 p.Thr201=

c.603G>A · VCV4936554

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00333%, amr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -14GERP -4.8
Overall
CADD2.65PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00333% Admixed American · 2/60,004 alleles
Filtering AF 0.000553% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000366%
Overall 0.00112% 18/1,613,856 alleles · very rare exomes 14/1,461,658 · genomes 4/152,198 · joint denominator
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.00333% 30,002
South Asian 0.0022% 45,545
Remaining individualsnot grpmax-eligible 0.0016% 62,464
Finnishnot grpmax-eligible 0.00156% 64,008
African / African-American 0.00133% 74,908
European (non-Finnish) 0.000932% 107,262

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SMARCD2
Protein
p.Thr201=
Coding
c.603G>A
MANE Select
NM_001098426
Type
single nucleotide variant
Location
chr17:63835532 (GRCh38)
Gene constraint
LOEUF 0.762 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 78.38
Full SMARCD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/smarcd2-p-thr201 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown